Omihub 40 Capsule contains Omeprazole 40mg, a proton pump inhibitor indicated for the treatment of acid-related disorders including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. It helps in reducing gastric acidity, relieving heartburn, and promoting ulcer healing.
Omeprazole works by selectively inhibiting the H+/K+ ATPase enzyme system in gastric parietal cells, suppressing acid secretion, and providing long-lasting relief from acid-related symptoms. Its capsule formulation ensures convenient oral administration and consistent therapeutic effect.
For distributors and healthcare suppliers, Omihub 40 Capsule is a high-demand gastric therapy product, commonly used in hospitals, clinics, and community pharmacies. The increasing prevalence of acid peptic disorders ensures steady year-round demand.
Adding Omihub 40 Capsule to your gastric acid and ulcer therapy segment creates strong opportunities in pharmacies, hospitals, gastroenterology clinics, export markets, and third-party manufacturing. Its proven efficacy, reliable formulation, and prescriber trust make it a valuable addition to pharmaceutical distribution portfolios.